1. Home
  2. PGY vs IDYA Comparison

PGY vs IDYA Comparison

Compare PGY & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGY
  • IDYA
  • Stock Information
  • Founded
  • PGY 2016
  • IDYA 2015
  • Country
  • PGY United States
  • IDYA United States
  • Employees
  • PGY N/A
  • IDYA N/A
  • Industry
  • PGY Finance: Consumer Services
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PGY Finance
  • IDYA Health Care
  • Exchange
  • PGY Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • PGY 2.6B
  • IDYA 2.3B
  • IPO Year
  • PGY N/A
  • IDYA 2019
  • Fundamental
  • Price
  • PGY $29.38
  • IDYA $28.39
  • Analyst Decision
  • PGY Strong Buy
  • IDYA Buy
  • Analyst Count
  • PGY 7
  • IDYA 17
  • Target Price
  • PGY $39.43
  • IDYA $48.20
  • AVG Volume (30 Days)
  • PGY 5.5M
  • IDYA 1.3M
  • Earning Date
  • PGY 11-10-2025
  • IDYA 11-04-2025
  • Dividend Yield
  • PGY N/A
  • IDYA N/A
  • EPS Growth
  • PGY N/A
  • IDYA N/A
  • EPS
  • PGY N/A
  • IDYA N/A
  • Revenue
  • PGY $1,153,015,000.00
  • IDYA $7,000,000.00
  • Revenue This Year
  • PGY $27.78
  • IDYA $90.17
  • Revenue Next Year
  • PGY $16.22
  • IDYA $219.42
  • P/E Ratio
  • PGY N/A
  • IDYA N/A
  • Revenue Growth
  • PGY 24.59
  • IDYA N/A
  • 52 Week Low
  • PGY $8.20
  • IDYA $13.45
  • 52 Week High
  • PGY $44.99
  • IDYA $32.67
  • Technical
  • Relative Strength Index (RSI)
  • PGY 44.62
  • IDYA 56.69
  • Support Level
  • PGY $26.95
  • IDYA $26.89
  • Resistance Level
  • PGY $30.34
  • IDYA $31.07
  • Average True Range (ATR)
  • PGY 2.29
  • IDYA 1.44
  • MACD
  • PGY 0.12
  • IDYA 0.07
  • Stochastic Oscillator
  • PGY 61.36
  • IDYA 46.81

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: